Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2002
10/02/2002EP1244455A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/02/2002EP1244453A1 Method and composition for the treatment of pain
10/02/2002EP1244452A1 Urotensin-ii receptor antagonists
10/02/2002EP1244451A1 Substituted piperazine and piperidine calcium channel blockers
10/02/2002EP1244448A2 Novel methods for the treatment and prevention of ileus
10/02/2002EP1244447A2 Novel methods and compositions involving opioids and antagonists thereof
10/02/2002EP1244446A1 Thrombopoietin mimetics
10/02/2002EP1244437A1 Tertiary amino compounds having opioid receptor affinity
10/02/2002EP1244436A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis
10/02/2002EP1244433A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule
10/02/2002EP1244432A2 Methods for pulmonary delivery of interleukin-2
10/02/2002EP1244359A1 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control
10/02/2002EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
10/02/2002EP1119321A4 Patient temperature regulation method and apparatus
10/02/2002EP1098648B1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof
10/02/2002EP1077964B1 Fumagillol derivatives and processes for preparing the same
10/02/2002EP1061961A4 Apparatuses and processes for whole-body hyperthermia
10/02/2002EP1047684B1 Substituted alpha,beta-anellated butyrolactones
10/02/2002EP1047450B1 Ace inhibitor-mmp inhibitor combinations
10/02/2002EP0996435B1 Amino acid derivatives useful to treat stroke
10/02/2002EP0984787B1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
10/02/2002EP0906279B1 Pyrrole derivatives
10/02/2002EP0853628B1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use
10/02/2002EP0841924B1 Benzimidazole compounds
10/02/2002EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002EP0717750B1 Double-stranded peptide nucleic acids
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002EP0691988B1 Inhibitor of stem cell proliferation and uses thereof
10/02/2002EP0651636B1 Chemotherapy for cancer
10/02/2002DE10115740A1 Zubereitung für die Restenoseprophylaxe Preparation for the prophylaxis of restenosis
10/02/2002DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility
10/02/2002DE10113513A1 Drug combination of kinase inhibitor and neurotropic factor, useful for treating and/or preventing nerve and/or glial cell damage, e.g. associated with neurodegenerative diseases
10/02/2002DE10112926A1 Use of sugar phosphate or aminoacid having e.g. transaminase inhibiting activity, for treating tumors and/or sepsis or inducing immunosuppression
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002DE10111486A1 Verwendung einer oder mehrerer neuroaktiver Substanzen zur Behandlung der Parkinsonschen Krankheit Using one or more of neuroactive substances for the treatment of Parkinson's disease
10/02/2002CN1372598A Methods of inducing cell death
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372566A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them
10/02/2002CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002CN1372556A Heterocyclic compound inhibiting angiogenesis
10/02/2002CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/02/2002CN1372545A 吲哚衍生物 Indole derivatives
10/02/2002CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
10/02/2002CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002CN1372469A Immunopotentiator
10/02/2002CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002CN1372450A Enhanced wound converage to enhance wound healing
10/02/2002CN1371713A Yilidan Chinese patent medicine
10/02/2002CN1371684A Novel biological activity of proglumide
10/02/2002CN1091770C Compounds useful as antiproliferative agents and GARFT inhibitors
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091766C Prenyl transferase inhibitors
10/02/2002CN1091599C Anti-HIV triple combination
10/02/2002CN1091598C Pharmaceutical use of benzothiophene
10/01/2002WO2001076630A1 Diagnostics and remedies for rheumatoid arthritis
10/01/2002US6459003 Ether compounds
10/01/2002US6458998 Naphthaleneureas as antidiabetic agents
10/01/2002US6458986 Intermediate for (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-α]imidazol-2-one
10/01/2002US6458963 Process for preparing eprosartan using regioselective protection of 2,4-disubstituted-imidazole intermediates
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458931 Immunoassay, immunotherapy; cancer; side effect reduction
10/01/2002US6458925 Peptide antagonists of zonulin and methods for use of the same
10/01/2002US6458850 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
10/01/2002US6458846 Ion channel modulating agents
10/01/2002US6458844 Antiinflammatory agents
10/01/2002US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/01/2002US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
10/01/2002US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an
10/01/2002US6458824 Solid preparation
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458816 Anticancer agents
10/01/2002US6458812 Muscarinic antagonists
10/01/2002US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002US6458805 Antagonists; especially sodium salts
10/01/2002US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
10/01/2002US6458794 Potassium channel inhibitors
10/01/2002US6458793 Heterocyclic derivatives which inhibit factor Xa
10/01/2002US6458788 4-hydroxycinnoline-3-carboxyamides as antiviral agents
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458785 Aids therapy
10/01/2002US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
10/01/2002US6458777 Methods and compositions for treating and preventing mucositis
10/01/2002US6458776 Inflammatory bowel disease
10/01/2002US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions
10/01/2002US6458763 Bone sialoprotein-based compositions for enhancing connective tissue repair
10/01/2002US6458575 Useful in the diagnosis, prevention, and treatment of cancer, autoimmune/inflammatory disorders, and reproductive disorders; screening libraries of peptides and antibodies; purification; amino acid sequences
10/01/2002US6458572 Phosphatidylglycerophosphate synthase from Staphylococcus aureus
10/01/2002US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation
10/01/2002US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002US6458360 Soluble complement regulatory molecules
10/01/2002US6458356 Antibody-induced apoptosis
10/01/2002US6458353 Anti-CCR2 antibodies and methods of use therefor
10/01/2002US6458338 Amino acid stabilized medicinal aerosol formulations
10/01/2002CA2404919A1 Diagnostic and therapeutic agents for rheumatoid arthritis
10/01/2002CA2272719C Apo b-secretion/mtp inhibitory amides
10/01/2002CA2248047C Antagonism of endothelin actions
1 ... 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 ... 1564